Biden has yet to speak with some longtime congressional allies post cancer diagnosis
Twenty-four hours after the Sunday announcement that former President Joe Biden has an aggressive form of prostate cancer, one of his staunchest supporters, Rep. Jim Clyburn of South Carolina, said Monday he had yet to connect with him. Another close Hill ally, Sen. Chris Coons, had not spoken with his fellow Delawarean as of midafternoon Tuesday.
Biden's longtime friend Bob Brady, the former House member from Pennsylvania who has known Biden for decades, said as of Tuesday afternoon that he hadn't talked with the former president directly since his cancer diagnosis, though he did touch base Monday with his family. All three said they planned to speak with him soon.
Before his cancer diagnosis, Biden had been taking the train from Delaware to Washington, meeting with his post-presidential staff, allies and former Cabinet secretaries, according to a Biden aide granted anonymity to speak freely. In New York City for his appearance on "The View," he met with former President Bill Clinton. And last week he met with Sen. Elissa Slotkin of Michigan, a rising star in the party.
But Biden, an inveterate creature of Washington who for most of his career seemed to gain life from glad-handing and working a room, hasn't yet talked to some longtime allies on Capitol Hill in the wake of his diagnosis. Months removed from his presidency, Biden has receded as a fixture of official Washington and has instead become a focal point of his party's recriminations — his planned reemergence after departing the White House running headlong into a devastating health diagnosis and an unsettled party growing increasingly anxious in the wilderness.
Some Democrats said they are drafting notes or plan to speak with him. Coons said he was working on finding a time to connect with Biden. Sen. Lisa Blunt Rochester of Delaware said she has reached out to people 'very close' to the family 'and just shared my love, my prayers.' Politicians on both sides of the aisle wished him well.
Most Democrats are trying, yet again, to pivot from Biden's health to stay on message as the GOP advances President Donald Trump's domestic agenda.
Rep. Gabe Amo of Rhode Island, the only former Biden White House aide who now serves in Congress, faulted Biden's critics for capitalizing on what he called the 'politics of the moment.'
'It's in their interest to talk about this rather than the issues of the day, so we're stuck in that unfortunate reality," Amo said. "I hope that people are focused on one, a legacy of public service, and two, wishing him well in his recovery.'
Or as Rep. Veronica Escobar of Texas, a Biden reelection co-chair, put it, 'We are living through a historic, terrifying backsliding of our democracy … I am so profoundly uninterested in talking about this issue.'
Not everyone wants to change the subject. Some Democrats, perhaps feeling burned by how Biden's decline was kept out of public view, are asking pointed questions about his cancer diagnosis — both publicly and privately.
On Monday, Ezekiel Emanuel, the oncologist and Biden's former pandemic adviser, opened the door on MSNBC's Biden-friendly 'Morning Joe' to a round of questions about Biden's health when he said that Biden 'did not develop [cancer] in the last 100, 200 days. He had it while he was president. He probably had it at the start of his presidency in 2021.'
At best for Democrats, his remarks scanned to some observers as concern about the care the president received while in office. At worst, they fueled more accusations of a White House cover-up.
In a Monday interview, Emanuel said he could not rule out the possibility that Biden had been diagnosed earlier but that information somehow wasn't released.
'Look, I'm not his doctor,' Emanuel said. 'I can't rule out that possibility because I don't know what transpired there.'
A spokesperson for Biden said Tuesday the former president's 'last known' prostate-specific antigen cancer screening test was in 2014 and that 'prior to Friday, President Biden had never been diagnosed with prostate cancer.'
This isn't the first time Biden has faced health challenges. When he was running for vice president in 2008, Biden disclosed that he had an enlarged prostate and a biopsy but that no evidence of cancer was found. His medical records also showed he had undergone prostate-specific antigen tests, which yielded normal results.
More than a decade later, when he was campaigning for the White House in 2019, Biden revealed he had been treated for his enlarged prostate, first with medication and later with surgery. The files stated he 'never had prostate cancer.'
Trump seized on questions surrounding the timeline of diagnosis — something that had quickly become an obsession of Biden's right-wing detractors online — telling reporters he was 'surprised that it wasn't, you know, the public wasn't notified a long time ago because to get to stage 9, that's a long time.' (Biden's diagnosis is stage-four prostate cancer.) Vice President JD Vance said he blamed the 'people around' Biden.
Asked about new allegations of a conspiracy to keep Biden's illness secret, Democratic Sen. Tim Kaine of Virginia said of Republicans advancing the idea, 'What a soulless bunch. Anybody who's spending time doing that, I'll pray for him in mass this Sunday.'
To some allies of Biden, who relied on a small and, critics said, insular circle of advisers during his presidency, even acknowledging such questions is fraught.
'This just feeds into the conspiracy theories. You have an electorate who doesn't pay attention, and this is breaking through,' said Democratic strategist Kellan White, who worked as a senior adviser to Biden's campaign in Pennsylvania in 2024. 'All a Gen Z voter who barely pays attention is hearing is, 'They weekend-at-Bernie-ed Joe Biden who now has cancer, which he probably had for 10 years.''
Rep. Sarah McBride (D-Del.), who's long been close to the Bidens, said in a brief interview she'd sent a message to the former president through his team and 'and expressed that I was praying for him and reiterated that he's in the hearts of every Delawarean right now.'
She said she'd spoken to him last at a St. Patrick's Day event in Wilmington and 'he seemed in good spirits. He seemed healthy.'
Biden's diagnosis came just as some of the Democratic Party's brightest stars had begun to grapple with questions about ramifications of his decision to run for reelection — and the fallout for the party.
'The historians will have to sort out the politics of the whole thing,' Rep. Jamie Raskin (D-Md.), who weathered his own cancer diagnosis, said in an interview.
He added that he had not spoken to Biden but was drafting him a note. He said, 'But at this point, there's nothing to do, but for those of us who love the guy, to express our solidarity and our sympathy.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Bill to amend medically assisted suicide law draws emotional debate from Maine lawmakers
Jun. 9—AUGUSTA — A proposal to allow doctors to waive the waiting period for terminally ill patients who want to be given life-ending drugs drew an emotional debate from lawmakers in the Maine Senate Monday before it was rejected by one vote. The fate of the bill is unclear after the Senate voted the proposal down 18-17. It passed 74-64 in the House of Representatives last week and faces another round of votes in each chamber before it could be sent to Gov. Janet Mills for her signature. The bill would amend a 2019 law known as the Death with Dignity Act, which legalized physician-assisted suicide in Maine. It allows certain terminally ill patients to have the option to receive life-ending medication so they have control over their death. Maine's law currently requires a 17-day waiting period from when a person requests the medication to when they can receive the prescription. The change under consideration, LD 613, would allow a doctor to waive all or a portion of the waiting period if they determine it would be in the patient's best interest. Mills supported the original Death with Dignity Act, but it's unclear if she would support the change. Spokespeople for the governor did not respond Monday to questions about whether she has taken a position on the bill. The proposal allowing for the waiting period to be waived drew emotional debate from lawmakers who spoke about how they've personally been affected by illness and death. "This is not an abstract issue for me," said Rep. Kathy Javner, R-Chester, who has metastatic breast cancer, during last week's House debate. "I am living this reality and stand before you today, not in despair, but in hope that we can preserve the dignity and meaning of life, even in the shadow of death." Javner, who was against the change, said removing the waiting period would take away the time that families and physicians currently have to reflect and consider alternative options. "Let us not respond to suffering with surrender," Javner said. "Let us respond with compassion, with presence, with resources for pain management, with palliative care, with love." Senate Minority Leader Trey Stewart, R-Presque Isle, talked about his mother, who died at age 50 from colorectal cancer, during Monday's Senate debate. Stewart said his mother "broke out" of hospice care in order to be at home with her family at the end of her life. "I will always be grateful for that extra month we got," Stewart said. "I worry about the scenarios about what if they don't get it right and what opportunities are we forestalling through this," he added. "This was the promise that was made originally with this policy, that there wouldn't be that knee-jerk opportunity because of this protection." Maine is among 10 states and Washington, D.C., where physician-assisted suicide is legal for people with terminal illnesses, according to Death With Dignity, an organization in Portland, Oregon, that advocates for the laws as a means of improving how people with such diagnoses die. Waiting periods for medication vary state to state and can range from one day to more than two weeks, according to Death With Dignity. Some states do allow waiting periods to be waived if the patient is unlikely to survive. Maine's Death with Dignity Act has been used by 218 people since it was enacted, according to Michele Meyer, D-Eliot, the sponsor of LD 613. But another nine people have died during the waiting period because their illnesses progressed too rapidly, Meyer said last week. She said the bill does not change the law's criteria that the patient be terminally ill with a six-month prognosis confirmed by two doctors and that they have the capacity to make informed decisions. "This is simple and straight forward," Meyer said. "It corrects a rare situation that never should have existed in the first place. Some of us will not know the gift of a long, healthy life. ... Medical aid in dying offers decisionally capable adults an option to avoid prolonged suffering." In the Senate Monday, Sen. Tim Nangle, D-Windham, talked about his father's lung cancer and the pain he suffered. Nangle said he didn't know if his father, who lived in another state, would have used the Death with Dignity Act, but he said the option for the time waiver should be there. "This is about their choice," Nangle said. "What do they want to do?" Copy the Story Link
CNBC
26 minutes ago
- CNBC
'Collateral damage': Fund managers lobby Congress over Section 899 to avert foreign investors leaving the U.S.
American fund managers are lobbying Congress over a provision tucked inside President Donald Trump's tax bill that they say could lead to foreign investors "quickly" pulling investments out of the U.S. The "One Big Beautiful Bill Act," which passed through the U.S. House of Representatives in May, aims to penalize foreign-owned firms operating in the U.S. and that are from countries with "unfair foreign taxes" under a provision known as Section 899. It is currently being considered by the Senate. The Investment Company Institute (ICI), which represents fund houses in the U.S., is lobbying Congress for an amendment as it warns the bill in its current form also impacts most foreign investments in U.S. stock markets, according to documents seen by CNBC. "In order to avoid the impact of section 899, portfolio investors are likely to retreat quickly from US equities, leading to capital outflows from the United States," the ICI said in a letter sent to Senator Mike Crapo, the chairman of the Senate Finance Committee, on June 5. "If sustained selling by foreign investors depresses US equity markets, this would harm both US companies and investors." Section 899 aims to introduce retaliatory tax measures against entities from countries that have levies such as the Digital Services Taxes and the OECD's global minimum tax rules. If signed into law, it could impact investors from the European Union, the United Kingdom, Canada, Australia, and Switzerland, among others. The tax would start at 5% and escalate by five percentage points annually to a maximum of 20%, on top of existing taxes, which vary by country and tax treaties. That could dent returns for foreign investors in U.S. equities. In the letter, the ICI also suggests that the U.S. fund management industry, which has collectively invested around $18 trillion in U.S. stock markets, would be "collateral damage" due to the impact of Section 899. "We do believe, however, that the current drafting of proposed section 899 should clarify its scope and avoid discouraging foreign investment in US equity markets through 'investment funds' such as US mutual funds and ETFs and their foreign counterparts (e.g., UCITS funds)," the ICI said. The letter to Senators goes on to say, "section 899 would penalize these funds and their shareholders by taxing passive income from US equity investments. To this end, investment funds would be collateral damage to the intended focus of section 899." Funds typically charge fees as a percentage of assets under management, and a withdrawal by foreign investors, over Section 899 concerns, could lead to lower earnings for the investment management firm. The Senate Finance Committee declined to comment, and Senator Mike Crapo's office did not respond to CNBC's request for comment. Foreign investors own $19 trillion in the U.S. stock markets, $7 trillion in U.S. government bonds, and $5 trillion in U.S. credit, according to data compiled by Apollo Global Management. The ICI said it's largely in support of the U.S. government's attempt to "protect US business interests overseas and to address discriminatory foreign taxes." However, it cautions that the current draft of the bill does the opposite. "Some foreign governments may actually cheer this capital flight from the United States because it benefits their local equity markets, which is not the behavioral incentive that Section 899 seeks to achieve," it said. Yuri Khodjamirian, chief investment officer for Tema ETFs, said investors in Europe who are focused on dividend-distributing U.S. companies would be "thinking quite carefully" about their holdings at this stage. "If suddenly you have to pay tax on that income, why would you hold that?" Khodjamirian questioned. Tema ETFs runs the American Reshoring ETF that is available to both U.S. and foreign investors. Tax experts suggest earnings paid out to foreign investors are more likely to be hit by Section 899 than capital gains and other methods of shareholder distributions. The Tema ETFs investment chief cautioned that the impact on the U.S. equities market would be relatively minimal as U.S. companies, say in the S&P 500, are typically not known for their dividends. "In the US, dividend yields are quite low. There's not a lot of companies paying. And most of the capital gets returned to share buybacks," Khodjamirian told CNBC. "Is that actually going to be that big of an issue then?"
Hamilton Spectator
27 minutes ago
- Hamilton Spectator
Auditor general's report on company behind ArriveCan to be released today
OTTAWA - The latest probe into the company behind the controversial ArriveCan app is among four reports being released today by Canada's auditor general. Karen Hogan looked into all contracts awarded and payments made to GC Strategies for its work on the app to determine whether they were in line with government policy and whether the government got value for taxpayers' money. In September, the House of Commons unanimously agreed to ask Hogan to look into the contracts and her report is set to be tabled in the House around 10 a.m. ET. As of March 2024, GC Strategies — a two-man team which last week was banned from entering into contracts or real property agreements with the federal government for seven years — had received $100 million in federal government contracts since 2011. Hogan's previous report on the app's development found it did not deliver the best value to taxpayers and concluded that three federal departments disregarded federal policies, controls and transparency in the contracting process. GC Strategies received nearly a third of the $60 million total cost of the ArriveCan project, despite being awarded contracts through non-competitive processes. Hogan also will table a report today on Canada's plans to purchase F-35 fighter jets and whether the Department of National Defence ensured the aircraft would be delivered on time and on budget. Another report will look at whether the government provides adequate office space for public servants while minimizing costs to taxpayers. Canada's environment commissioner Jerry DeMarco will also table four reports today, including an audit of the National Adaptation Strategy, the federal government's $2.1 billion initiative to help communities withstand the impacts of climate change. This report by The Canadian Press was first published June 10, 2025.
